Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Matter Bio
Brooklyn, New York, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
Matter Bio is conducting the largest comparative analysis of longevity genetics for new aging interventions; initiating Phase 1/2a cancer trial in humans.
- Therapeutic areas
- OncologyOther
- Modalities
- Gene therapyEngineered bacteria therapySmall moleculeAntisense oligonucleotide
- Industry
- Biotech
02
Partnerships
HarvardMITUniversity of RochesterAlbert Einstein College of MedicineUniversity of MinnesotaAmerican Federation for Aging Research
Beyond the preview
Go deeper on Matter Bio.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Matter Bio.